What is the treatment for pericarditis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Pericarditis

First-line treatment for acute pericarditis consists of high-dose NSAIDs (aspirin 750-1000 mg every 8 hours or ibuprofen 600 mg every 8 hours) combined with colchicine (0.5 mg twice daily if ≥70 kg, or 0.5 mg once daily if <70 kg) for 3 months, with gastroprotection. 1

Initial Management Algorithm

First-Line Therapy (Start Immediately)

NSAIDs or Aspirin:

  • Aspirin 500-1000 mg every 6-8 hours (total 1.5-4 g/day) OR ibuprofen 600 mg every 8 hours (total 1200-2400 mg/day) 2, 1
  • Continue for 1-2 weeks at full dose until symptoms resolve and CRP normalizes 1, 3
  • Taper gradually: decrease aspirin by 250-500 mg every 1-2 weeks, or ibuprofen by 200-400 mg every 1-2 weeks 2
  • Always provide gastroprotection (proton pump inhibitor) 1

Colchicine (Mandatory Addition):

  • Weight-adjusted dosing: 0.5 mg twice daily if ≥70 kg, or 0.5 mg once daily if <70 kg 2, 1
  • Continue for 3 months minimum 1, 3
  • This combination reduces recurrence from 37.5% to 16.7% (absolute risk reduction 20.8%) 3

Monitoring Response

  • Use CRP levels to guide treatment duration and assess response 1
  • Only attempt tapering when symptoms are absent AND CRP is normal 2, 1
  • Taper one drug class at a time before discontinuing colchicine 2

Activity Restriction

  • Restrict exercise until symptoms resolve and CRP, ECG, and echocardiogram normalize 2, 1
  • For athletes specifically: minimum 3 months of exercise restriction 2, 1

Second-Line Therapy (When First-Line Fails)

Corticosteroids are NOT first-line therapy because they promote chronicity, increase recurrence rates, and cause more side effects. 2, 1

Use corticosteroids only if:

  • True contraindication to NSAIDs (allergy, recent peptic ulcer, gastrointestinal bleeding, high bleeding risk on anticoagulation) 2
  • Failure of NSAIDs plus colchicine after adequate trial 1
  • Specific indications: systemic inflammatory diseases, post-pericardiotomy syndrome, pregnancy 2
  • Infectious causes (especially bacterial and TB) have been excluded 2

Corticosteroid Dosing (if required):

  • Start low-to-moderate dose: prednisone 0.2-0.5 mg/kg/day 2, 1
  • Add to NSAIDs and colchicine as triple therapy—do not replace them 2
  • Taper extremely slowly using this protocol 2:
    • 50 mg: decrease by 10 mg every 1-2 weeks

    • 50-25 mg: decrease by 5-10 mg every 1-2 weeks
    • 25-15 mg: decrease by 2.5 mg every 2-4 weeks
    • <15 mg: decrease by 1.25-2.5 mg every 2-6 weeks (critical threshold for recurrence) 2
  • Provide calcium 1200-1500 mg/day plus vitamin D 800-1000 IU/day 2
  • Consider bisphosphonates for men ≥50 years and postmenopausal women on long-term therapy 2

Recurrent Pericarditis Management

For first recurrence:

  • Continue NSAIDs/aspirin at full doses 2
  • Extend colchicine to at least 6 months (not 3 months) 2, 3
  • If inadequate response, add low-dose corticosteroids as triple therapy 2

For multiple recurrences or corticosteroid-dependent disease:

  • Consider IL-1 blockers (anakinra, rilonacept, goflikicept) before escalating corticosteroid doses 2, 3, 4
  • Alternative immunomodulatory agents: IVIG, azathioprine (require multidisciplinary consultation with immunology/rheumatology) 2, 5
  • Pericardiectomy only as last resort after thorough trial of medical therapy at specialized centers 2, 5

Critical Pitfalls to Avoid

Inadequate initial treatment is the most common cause of recurrence. 2, 1

  • Never use corticosteroids as first-line therapy—they increase recurrence rates from 15-30% to 50% after first recurrence 2, 1
  • Do not taper medications while symptoms persist or CRP remains elevated 2, 1
  • Avoid rapid tapering of any medication, especially corticosteroids 2
  • Do not increase corticosteroid dose or reinstate them if recurrence occurs during taper—instead optimize NSAIDs and colchicine 2
  • Ensure adequate treatment duration: weeks to months, not days 2

Special Etiologies Requiring Different Approaches

Tuberculous pericarditis:

  • Antituberculous therapy: isoniazid 300 mg/day, rifampin 600 mg/day, pyrazinamide 15-30 mg/kg/day, ethambutol 15-25 mg/kg/day 6
  • Add prednisone 1-2 mg/kg/day for 5-7 days, then taper over 6-8 weeks 6
  • Mortality approaches 85% if untreated 6
  • High risk (20-30%) of developing constrictive pericarditis 2

Purulent/bacterial pericarditis:

  • Urgent pericardial drainage is mandatory 6
  • IV antibiotics: vancomycin 1g twice daily, ceftriaxone 1-2g twice daily, ciprofloxacin 400 mg/day 6
  • Open surgical drainage preferred over catheter drainage 6
  • 40% mortality even with treatment; fatal if untreated 6

Autoimmune/post-pericardiotomy syndrome:

  • Same first-line therapy (NSAIDs + colchicine), but corticosteroids may be added earlier 2, 7
  • Intermediate risk (2-5%) of constrictive pericarditis 2

References

Guideline

Initial Treatment for Pericarditis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Alternative Treatments to Colchicine for Pericarditis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Bacterial pericarditis: diagnosis and management.

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.